Johnson & Johnson MedTech, a global leader in orthopaedic technologies and solutions, is highlighting its latest advancements in digital orthopaedics at the American Academy of Orthopaedic
CollPlant Biotechnologies , or 'CollPlant', a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and medical aesthetics, today provided a corporate update.
BIOTRONIK Neuro will unveil new data from the BENEFIT-03 clinical study. The findings highlight the transformative potential of its ProsperaTM Spinal Cord Stimulation (SCS) system.
Zymo Research is proud to introduce the Master the Microbiome Grant, a global initiative dedicated to advancing research in microbiomics, metagenomics, and microbial sciences. This grant empowers researchers by providing access to industry-leading sample and library preparation solutions and services, as well as opportunities to share their research with the field at-large.
A team of international researchers led by scientists at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States, with its National Medical Center in Los Angeles ranked among the nation’s top 5 cancer centers by U.S. News & World Report, have demonstrated a way to boost thymic function after damage in preclinical studies.
Vaxxas, a clinical-stage biotechnology company commercializing a novel high-density microarray patch (HD-MAP) vaccination platform, has been named a Concept Stage winner of the United States Biomedical Advanced Research and Development Authority’s (BARDA’s) $50 million Patch Forward Prize.
Viralgen and two labs based in the Broad Institute of MIT and Harvard University have partnered to develop and manufacture an innovative approach to gene therapy for prion disease. This partnership aims to deliver life-changing treatment to patients at risk or suffering from this rapidly progressive neurodegenerative disorder.
The Biomedical Division of PHC Corporation (Headquarters: Chiyoda-ku, Tokyo, Japan; President: Nobuaki Nakamura), has received a 2024 Innovation Award from The Analytical Scientist1 for its live cell metabolic analyzer, LiCellMoTM. LiCellMo, launched for research use in Japan in September and the United States, UK, EU, China and other Asian select geographies in October2.
Stock up your family's medicine cabinet this Black Friday and Cyber Monday. WELLlife, a leading innovator in medical diagnostic and testing solutions, is increasing accessibility to respiratory illness testing in preparation for the year-end holidays.
Nevro Corp. a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that it has received CE Mark Certification in Europe for its HFX iQ™ spinal cord stimulation (SCS) system. The CE marking allows Nevro to market HFX iQ in all countries that recognize this certification.